We are developing an Immunotherapeutic Approach to the Treatment of Early and Mid-Stage Alzheimer Dementias

Invest in EquityNet Crowdfunding to Help Develop Our New Alzheimer Treatment:
www.equitynet.com/c/augustus-biotarget-inc

For more information visit the Alzheimer’s Disease Project page.

Posted in News